Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: HiberGene Diagnostics Begins Manufacturing for Meningitis MDx Test

Premium

Ireland's HiberGene Diagnostics said this week that it has begun manufacturing its molecular diagnostic test for meningococcal meningitis.

HiberGene, based in Dublin, is a startup company of NovaUCD, an innovation and technology transfer center. The company licensed its meningitis test from Belfast Health and Social Care Trust.

HiberGene's test is based on loop-mediated isothermal amplification. According to the company's website, the test can be performed in less than 40 minutes, is 100 percent sensitive and 99.7 percent specific, and requires minimal laboratory instrumentation.

The company said it is also developing a molecular diagnostic test for pneumococcal meningitis using the same technology.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.